Compare SOCA & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOCA | PYXS |
|---|---|---|
| Founded | 2025 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.0M | 243.5M |
| IPO Year | 2025 | 2021 |
| Metric | SOCA | PYXS |
|---|---|---|
| Price | $10.09 | $4.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 28.5K | ★ 797.0K |
| Earning Date | 01-01-0001 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,820,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.94 | $0.83 |
| 52 Week High | $10.15 | $5.55 |
| Indicator | SOCA | PYXS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 48.86 |
| Support Level | N/A | $3.67 |
| Resistance Level | N/A | $4.61 |
| Average True Range (ATR) | 0.00 | 0.45 |
| MACD | 0.00 | -0.13 |
| Stochastic Oscillator | 0.00 | 29.79 |
Solarius Capital Acquisition Corp is a blank check company.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.